Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.

Market OverviewThe Lung In Vitro Model Market has been experiencing significant growth, driven by advancements in ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

Thousands of people in the UK who take the medication are being encouraged to make the diet change to avoid side effects ...

Non-communicable diseases pose a significant global health challenge, requiring preventive measures and lifestyle changes for ...

Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...